AGE AND LOSARTAN EFFECTS ON MITOCHONDRIAL PROTEOME IN MICE

Adam Said, Michael Bene, Michael Abadir, Simion Kreimer, Ruth Marx, Laura Powell, Jeremy Walston · 2024

Read AGE AND LOSARTAN EFFECTS ON MITOCHONDRIAL PROTEOME IN MICE by Adam Said, Michael Bene, Michael Abadir, Simion Kreimer, Ruth Marx, Laura Powell, Jeremy Walston (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11692072.txt.

Description

Adam Said and six co-authors published a study in 2024 on how age and losartan, a common blood pressure drug, affect the mitochondrial proteome in mice. Mitochondria are the structures inside cells that produce energy, and they lose function with age, which is linked to weaker organs and more disease. Losartan blocks part of a hormone system that interacts with mitochondria.

The researchers analyzed mitochondrial samples from young mice, aged mice, and aged mice treated with losartan. Aged mice showed lower levels of proteins involved in fat burning and amino acid breakdown, while chaperone and muscle contraction proteins increased. In treated mice at an older but not the oldest age, losartan reversed much of that pattern. At the oldest age tested, the drug showed no clear effect. The findings suggest that any benefit of the drug may fade at very advanced ages.

Catalog record

CREATORAdam Said, Michael Bene, Michael Abadir, Simion Kreimer, Ruth Marx, Laura Powell, Jeremy Walston
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11692072

Browse the full library · About the Tower of Babel